Cold pain therapy is a therapeutic approach that utilizes cold temperatures or ice application to alleviate pain, reduce swelling, and manage inflammation. This method is commonly employed in the treatment of various injuries, such as sprains, strains, and joint inflammation, by constricting blood vessels and slowing nerve impulses, which helps mitigate pain sensations. 

Wilmington, New Castle, Delaware, March 01, 2024 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Cold Pain Therapy Market by Product (OTC Products and Prescription Products), Application (Musculoskeletal Disorders, Post-Operative Therapy, Sports Injuries and Post-Trauma Therapy), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2023–2032.”. According to the report, the global cold pain therapy market was valued at $1.9 billion in 2022, and is projected to reach $3 billion by 2032, growing at a CAGR of 5.1% from 2023 to 2032. 

Prime Determinants of Growth

The cold pain therapy market has experienced significant growth owing to increase in the number of sports related injuries, increase in the number of surgical procedures, and rise in the number of traumatic injury cases. 

Request Sample of the Report on Cold Pain Therapy Market Forecast 2032 – https://www.alliedmarketresearch.com/request-sample/A09540 

Report Coverage & Details

Report Coverage	Details
Forecast Period	2023–2032
Base Year	2022
Market Size In 2022	$1.9 Billion
Market Size In 2032	$3 Billion
CAGR	5.10%
No. Of Pages In Report	240
Segments Covered	Product, Application, Distribution Channel and Region.
Drivers	Increase In the Number of Sports Related Injuries,
	Increase In the Number of Surgical Procedures
	Rise In the Number of Traumatic Injury Cases
Opportunities	Availability of Low-Priced Analgesic Pills for Pain Relief.
Restraints	Rise in the Prevalence of Musculoskeletal Disorders.

  2023 Recession Impact Analysis 

• The global recession has significant impact on cold pain therapy market. 
• The high inflation rate and the economic uncertainty has created financial distress for the manufactures of the cold pain therapy products. 
• The fluctuating oil prices due to dispute between major oil producing countries has caused in rise in supply chain cost.
• However, market for cold pain therapy is expected to recover owing to rise in geriatric population.  

Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/A09540 

The OTC product segment to maintain its leadership status throughout the forecast period 

By product, the OTC product segment held the highest market share in 2022, accounting for more than half of cold pain therapy market revenue, owing to high adoption of OTC product such as creams and gels. 

The musculoskeletal disorders segment to maintain its leadership status throughout the forecast period 

By application, the musculoskeletal disorders segment held the highest market share in 2022, accounting for almost two fifth of cold pain therapy market revenue. This is attributed to high prevalence of the musculoskeletal disorders and rise in geriatric population. 

The retail pharmacies segment to maintain its leadership status throughout the forecast period 

By distribution channel, the retail pharmacies segment held the highest market share in 2022, accounting for almost half of cold pain therapy market revenue, owing to the immediate availability of the cold pain therapy products and high sales of OTC cold pain therapy product through retail pharmacies. 

The North America segment to maintain its leadership status throughout the forecast period 

Based on region, the North America segment held the highest market share in 2022, accounting for almost half of cold pain therapy market revenue. This is attributed to rise in the prevalence of orthopedic disorders coupled with favorable reimbursement scenario, increase in participation in sports related activities, well-defined regulatory framework and observation guidelines, sophisticated healthcare infrastructure, and strong presence of key players providing cold pain therapy products. However, Asia Pacific segment is expected to register highest CAGR during the forecast period, this is attributed to increase in geriatric population, increases in the incidence of road-accidents and musculoskeletal disease in the region. 

For Procurement Information – https://www.alliedmarketresearch.com/purchase-enquiry/A09540 

Leading Market Players 

• Romsons Group of Industries 
• Cardinal Health Inc 
• Sanofi 
• Breg Inc. 
• Medline Industries LP 
• Ossur 
• Hisamitsu Pharmaceutical Inc 
• Beiersdorf AG 
• 3M 
• ThermoTek Inc  

The report provides a detailed analysis of these key players in the cold pain therapy market. These players have adopted different strategies such as collaboration to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.  

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

Contact 
David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 

[email protected]   

Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter